Elevance Health, Inc. (LON:0HG8)
| Market Cap | 53.64B |
| Revenue (ttm) | 144.93B |
| Net Income (ttm) | 4.12B |
| Shares Out | n/a |
| EPS (ttm) | 18.14 |
| PE Ratio | 13.03 |
| Forward PE | 11.81 |
| Dividend | 5.13 (1.64%) |
| Ex-Dividend Date | Sep 10, 2025 |
| Volume | 705 |
| Average Volume | 1,369 |
| Open | 310.93 |
| Previous Close | 316.96 |
| Day's Range | 310.93 - 314.35 |
| 52-Week Range | 273.50 - 458.75 |
| Beta | 0.53 |
| RSI | 33.73 |
| Earnings Date | Oct 15, 2025 |
About Elevance Health
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, a... [Read more]
Financial Performance
In 2024, Elevance Health's revenue was $176.81 billion, an increase of 3.19% compared to the previous year's $171.34 billion. Earnings were $5.98 billion, a decrease of -0.12%.
Financial numbers in USD Financial StatementsNews
Elevance Health (ELV) Sees Price Target Reduction by Mizuho | ELV Stock News
Elevance Health (ELV) Sees Price Target Reduction by Mizuho | ELV Stock News
Columbia Balanced Fund Q3 2025 Portfolio Update
Electronic Arts' shares outperformed the broader market during the period, driven by renewed investor confidence and momentum surrounding several high-profile product announcements. eBay's shares surg...
Artisan Global Value Fund Q3 2025 Portfolio Update
Alphabet shares rose 38% during the quarter, which represents a striking $810 billion increase in market value. Samsung shares rose 36% in the quarter, adding over $100 billion of market value. Elevan...
Implied Volatility Surging for Elevance Health Stock Options
Investors need to pay close attention to ELV stock based on the movements in the options market lately.
Martin Zweig Detailed Fundamental Analysis - ELV
Below is Validea's guru fundamental report for ELEVANCE HEALTH INC (ELV). Of the 22 guru strategies we follow, ELV rates highest using our Growth Investor model based on the published strategy of Mart...
Elevance Health Inc: A Key Exit in Eaton Vance Worldwide Health Sciences Fund's Q3 2025 Portfolio
Elevance Health Inc: A Key Exit in Eaton Vance Worldwide Health Sciences Fund's Q3 2025 Portfolio
Elevance Health: Q3 Figures Underscore Slow But Steady Recovery
Elevance Health Inc at Wells Fargo Healthcare Conference Transcript
Elevance Health Inc at Wells Fargo Healthcare Conference Transcript
Elevance Health Inc at Bernstein Strategic Decisions Conference Transcript
Elevance Health Inc at Bernstein Strategic Decisions Conference Transcript
Elevance Health Inc at UBS Global Healthcare Conference Transcript
Elevance Health Inc at UBS Global Healthcare Conference Transcript
Elevance Health Inc at Goldman Sachs Global Healthcare Conference Transcript
Elevance Health Inc at Goldman Sachs Global Healthcare Conference Transcript
Elevance Health Inc at Sanford C Bernstein Strategic Decisions Conference Transcript
Elevance Health Inc at Sanford C Bernstein Strategic Decisions Conference Transcript
Elevance Health Inc Annual Shareholders Meeting Transcript
Elevance Health Inc Annual Shareholders Meeting Transcript
Elevance Health Inc at Barclays Global Healthcare Conference Transcript
Elevance Health Inc at Barclays Global Healthcare Conference Transcript
Elevance Health Inc at TD Cowen Health Care Conference Transcript
Elevance Health Inc at TD Cowen Health Care Conference Transcript
TD Cowen Raises Price Target for Elevance Health (ELV) to $380 | ELV Stock News
TD Cowen Raises Price Target for Elevance Health (ELV) to $380 | ELV Stock News
Elevance Health Named Top Dividend Stock With Insider Buying and 1.96% Yield (ELV)
In this series, we look through the most recent Dividend Channel ''DividendRank'' report, and then we cherry pick only those companies that have experienced insider buying within the past six months. ...
US health insurance premiums rose to $27,000 for families in 2025
Annual premiums for U.S. families with employer-sponsored health insurance in 2025 rose 6% to nearly $27,000, reflecting higher spending on popular weight-loss treatments and other prescription drugs,...
Barclays Lowers Price Target for Elevance Health (ELV) to $385 | ELV Stock News
Barclays Lowers Price Target for Elevance Health (ELV) to $385 | ELV Stock News
HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members
MINNEAPOLIS--(BUSINESS WIRE)-- #HistoSonics--HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members.
Elevance: Checking Out The Q3 Report
Elevance Health, Inc. reported Q3 results, beating consensus earnings estimates. Click here to read why ELV stock is a Hold.
Elevance Health Inc (ELV): A Strategic SWOT Insight
Elevance Health Inc (ELV): A Strategic SWOT Insight
Elevance Health (ELV) Maintains Quarterly Dividend at $1.71 Per Share
Elevance Health (ELV) Maintains Quarterly Dividend at $1.71 Per Share
Elevance Health (ELV) Faces Challenges Despite Strong Revenue Growth
Elevance Health (ELV) Faces Challenges Despite Strong Revenue Growth